United Kingdom · 
Who invested in TrialReach?
TrialReach's investors include Amadeus Capital Partners, Octopus Ventures and Smedvig Capital.
2012201320142015
$1.2MVenture$3.2MSeries A$14MSeries B
United Kingdom · Series B startup
Who invested in TrialReach
Funding summaryUpdated 26 Oct 2026
$18Mraised across 3 rounds since 2011, from 3 sources
$1.2MVenture$3.2MSeries A$14MSeries B
- Latest round
- Series B, $14MFeb 2015
- Step-upi
- 4.2×
- Investors
- 3
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Venture, $1.2M Oct 2011
- Biggest round
- $14M Series B · Feb 2015
- Usual gap between rounds
- 21 months the median of 2
The rounds
- Feb 2015Series B$14M1 new2 returning
From a historical funding record
- May 2013
- Oct 2011
Funding filed with regulators
TrialReach filed 2 raises, $25M in all. Filings say how much was sold and to how many investors; they never name the investors.
- Sept 2024$1.3MUK share allotment
- Jun 2021$24MUK share allotment
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about TrialReach
How much has TrialReach raised?
TrialReach has raised $18M across 3 rounds since 2011.
When did TrialReach last raise?
TrialReach's most recent round was a Series B of $14M in Feb 2015.
What was TrialReach's biggest round?
Its most recent round, $14M in Feb 2015, is also its largest on record.
Who backed TrialReach first?
TrialReach's first round on record, in Oct 2011, was backed by Amadeus Capital Partners.
What stage is TrialReach at?
TrialReach's latest named round is a Series B, in Feb 2015.
Where is TrialReach based?
TrialReach is based in the United Kingdom.
Companies like TrialReach
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.